Aptabridge Therapeutics
PrivateLast Round
Grant
Jun 16, 2023
Total Funding Raised
$103,000
Company Overview
Aptabridge Therapeutics is a biotechnology company that develops a drug design platform leveraging DNA nanoparticles for immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptabridge Therapeutics Comparables
Compare Aptabridge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DoriNano | 79% | |
| Aptadel Therapeutics | 77% | |
| NextRNA Therapeutics | 73% |
Aptabridge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2023 | ||||
| Seed | May 16, 2023 |
Aptabridge Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins University Endowment | Grant |
| FastForward U | Seed |
| HopStone Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2023
$100K grant from Johns Hopkins University Endowment
- May 16, 2023
$3K round from FastForward U and HopStone Capital.
Aptabridge Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aptabridge Therapeutics's valuation, stock price, and market status.
Is Aptabridge Therapeutics a public or private company?
Aptabridge Therapeutics is a private company.
What is the current stock price of Aptabridge Therapeutics?
Aptabridge Therapeutics is a private company with no public stock price. Caplight tracks Aptabridge Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Aptabridge Therapeutics worth (valuation)?
Valuation information for Aptabridge Therapeutics is not publicly available.
Can I buy Aptabridge Therapeutics stock?
Aptabridge Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aptabridge Therapeutics's last funding round?
Aptabridge Therapeutics's most recent funding round was Grant on June 16, 2023.
Who are the main investors in Aptabridge Therapeutics?
Key investors in Aptabridge Therapeutics include Johns Hopkins University Endowment, FastForward U, HopStone Capital.
Will Aptabridge Therapeutics IPO soon?
No public IPO plans have been announced for Aptabridge Therapeutics.
How can I track Aptabridge Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aptabridge Therapeutics's secondary market activity and sign up for updates.